Johnson & Johnson

This 10-Stock Dividend Strategy Is Trouncing the Dow

Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products

DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales

4 Pharmaceutical Stocks to Buy Now

Johnson & Johnson Outlines Poppy Supply Plans

Buy Backs Boosting the Market

The Risperdal Lawsuits Keep On Coming: Kentucky Sues J&J

Correction to Thursday's Johnson & Johnson-Metal-on-Metal

J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports

These Blue Chips Are Cheaper Than You Think